Published in J Clin Microbiol on June 01, 1983
Comparison of nasopharyngeal aspirate and nasopharyngeal swab specimens for respiratory syncytial virus diagnosis by cell culture, indirect immunofluorescence assay, and enzyme-linked immunosorbent assay. J Clin Microbiol (1987) 3.06
Comparison of directigen RSV with viral isolation and direct immunofluorescence for the identification of respiratory syncytial virus. J Clin Microbiol (1990) 2.15
Rapid detection of respiratory syncytial virus in nasopharyngeal secretions by enzyme-linked immunosorbent assay. J Clin Microbiol (1985) 2.10
Monoclonal antibodies against respiratory syncytial virus and their use for rapid detection of virus in nasopharyngeal secretions. J Clin Microbiol (1985) 1.96
Detection, pathogenesis, and therapy of respiratory syncytial virus infections. Clin Microbiol Rev (1988) 1.92
Detection of respiratory syncytial virus in clinical specimens by viral culture, direct and indirect immunofluorescence, and enzyme immunoassay. J Clin Microbiol (1988) 1.88
Evaluation of a monoclonal antibody pool for rapid diagnosis of respiratory viral infections. J Clin Microbiol (1989) 1.69
Rapid detection of respiratory syncytial virus in nasopharyngeal aspirates by a commercial enzyme immunoassay. J Clin Microbiol (1986) 1.67
Nasopharyngeal swabs and nasopharyngeal aspirates equally effective for the diagnosis of viral respiratory disease in hospitalized children. J Clin Microbiol (1989) 1.66
Practical recommendations for the detection of pediatric respiratory syncytial virus infections. J Clin Microbiol (1985) 1.65
Comparison of two new tests for rapid diagnosis of respiratory syncytial virus infections by enzyme-linked immunosorbent assay and immunofluorescence techniques. J Clin Microbiol (1986) 1.61
Production of monoclonal antibodies against parainfluenza 3 virus and their use in diagnosis by immunofluorescence. J Clin Microbiol (1985) 1.11
Use of nasal and pharyngeal swabs for rapid detection of respiratory syncytial virus and adenovirus antigens by enzyme-linked immunosorbent assay. J Clin Microbiol (1989) 0.95
Rapid diagnosis of respiratory syncytial virus infection by using Pernasal swabs. J Clin Microbiol (1991) 0.95
Rapid diagnosis of respiratory syncytial virus infection by antigen immunofluorescence detection with monoclonal antibodies and immunoglobulin M immunofluorescence test. J Clin Microbiol (1986) 0.92
Clinical laboratory applications of monoclonal antibodies. Clin Microbiol Rev (1988) 0.91
Rapid detection of respiratory syncytial virus in nasopharyngeal specimens obtained with the rhinoprobe scraper. J Clin Microbiol (1990) 0.90
Surveillance of respiratory viral infections by rapid immunofluorescence diagnosis, with emphasis on the epidemiological development of respiratory syncytial virus infections. J Hyg (Lond) (1985) 0.85
Etiological diagnosis of influenza A virus by enzymatic radioimmunoassay. J Clin Microbiol (1984) 0.75
Rapid diagnosis of respiratory syncytial virus infection by immunofluorescent antibody techniques. Br Med J (1968) 5.56
Clinically useful method for the isolation of respiratory syncytial virus. J Infect Dis (1975) 5.00
The late detection of respiratory syncytial virus in cells of respiratory tract by immunofluorescence. J Hyg (Lond) (1970) 4.08
Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: application to clinical samples. J Clin Microbiol (1982) 3.22
Comparison of virus culturing and immunofluorescence for rapid detection of respiratory syncytial virus in nasopharyngeal secretions: sensitivity and specificity. J Clin Microbiol (1982) 2.05
Respiratory syncytial virus infection. Rapid diagnosis in children by use of indirect immunofluorescence. Am J Dis Child (1978) 1.90
Summary of a workshop on new and useful methods in viral diagnosis. J Infect Dis (1978) 1.87
Comparison of direct and indirect immunofluorescence staining of clinical specimens for detection of respiratory syncytial virus antigen. J Clin Microbiol (1982) 1.72
Nosocomial respiratory syncytial virus infections in an intensive care nursery: rapid diagnosis by direct immunofluorescence. Pediatrics (1979) 1.49
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol (2000) 7.78
A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med (1997) 7.11
Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med (1993) 5.67
Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. N Engl J Med (1983) 5.41
Clinically useful method for the isolation of respiratory syncytial virus. J Infect Dis (1975) 5.00
Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein. J Virol (1983) 4.05
Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med (1982) 3.93
SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol (1997) 3.84
Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus. J Virol (1986) 3.64
Structure of hepatitis B Dane particle DNA before and after the Dane particle DNA polymerase reaction. J Virol (1977) 3.57
Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med (1986) 3.43
Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis (1991) 3.27
Respiratory syncytial virus infection in adults. Clin Microbiol Rev (2000) 3.16
Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol (1998) 3.06
Blood contacts during surgical procedures. JAMA (1991) 3.03
Percutaneous injuries during surgical procedures. JAMA (1992) 3.01
Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies. Infect Immun (1984) 2.86
Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med (1994) 2.84
Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J Virol (1988) 2.84
Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol (1985) (1986) 2.77
Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J Immunol (1985) 2.63
Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients. JAMA (1997) 2.62
Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group. Ann Intern Med (1993) 2.45
Respiratory syncytial virus infections in infants: quantitation and duration of shedding. J Pediatr (1976) 2.45
Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J Clin Microbiol (1986) 2.43
Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis (1990) 2.41
Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J Gen Virol (1987) 2.39
Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA (1985) 2.34
Purification and characterization of the respiratory syncytial virus fusion protein. J Gen Virol (1985) 2.31
Low blood pressure and the risk of dementia in very old individuals. Neurology (2003) 2.30
Primary human herpesvirus 6 infection in young children. N Engl J Med (1992) 2.30
Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus. J Gen Virol (1984) 2.30
Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J Virol (1987) 2.26
Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies. Ann Intern Med (1978) 2.25
Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. J Am Geriatr Soc (1992) 2.17
Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis. Arch Pediatr Adolesc Med (2000) 2.15
Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis (2000) 2.13
Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol (1986) 2.09
Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections. J Pediatr (1978) 2.01
Respiratory syncytial virus infections within families. N Engl J Med (1976) 1.99
Severity of respiratory syncytial virus infection is related to virus strain. J Infect Dis (1997) 1.98
Missed opportunities for childhood vaccinations in office practices and the effect on vaccination status. Pediatrics (1993) 1.97
Viral shedding patterns of children with influenza B infection. J Infect Dis (1979) 1.91
Possible transmission by fomites of respiratory syncytial virus. J Infect Dis (1980) 1.87
Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 1.86
Respiratory syncytial virus proteins: identification by immunoprecipitation. J Virol (1981) 1.86
Nosocomial respiratory syncytial virus infections. N Engl J Med (1975) 1.85
Modes of transmission of respiratory syncytial virus. J Pediatr (1981) 1.84
Neonatal respiratory syncytial virus infection. N Engl J Med (1979) 1.82
Children with influenza A infection: treatment with rimantadine. Pediatrics (1987) 1.80
Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J Clin Microbiol (1986) 1.79
Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis (2001) 1.79
Variable adherence of fimbriated Haemophilus influenzae type b to human cells. Infect Immun (1985) 1.77
Is underimmunization a marker for insufficient utilization of preventive and primary care? Arch Pediatr Adolesc Med (1995) 1.77
Comparison of two human papovaviruses with simian virus 40 by structural protein and antigenic analysis. J Virol (1974) 1.76
Immunization practices of pediatricians and family physicians in the United States. Pediatrics (1994) 1.75
Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr (1985) 1.73
Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model. J Infect Dis (1985) 1.71
Production of unique C-type viruses by chicken cells grown in bromodeoxyuridine. Virology (1976) 1.70
Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses. J Gen Virol (1986) 1.67
Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. J Pediatr (1990) 1.64
The proteins of hepatitis B Dane particle cores. J Med Virol (1977) 1.62
White matter abnormalities in mobility-impaired older persons. Neurology (2000) 1.61
Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity. J Clin Microbiol (1988) 1.60
Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial viral infection. J Pediatr (1988) 1.60
Variation in severity of respiratory syncytial virus infections with subtype. J Pediatr (1990) 1.60
Investigations of patients of health care workers infected with HIV. The Centers for Disease Control and Prevention database. Ann Intern Med (1995) 1.59
Somatic mutation and recombination test in Drosophila melanogaster. Environ Mutagen (1984) 1.56
Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin Infect Dis (1998) 1.55
Influenza surveillance in community-dwelling elderly compared with children. Arch Fam Med (1997) 1.55
Detection of IgA and IgG but not IgE antibody to respiratory syncytial virus in nasal washes and sera from infants with wheezing. J Pediatr (2001) 1.53
Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med (1981) 1.52
Cellular localization of human herpesvirus-6 in the brains of children with AIDS encephalopathy. J Neurovirol (1995) 1.52
Validation of dual x-ray absorptiometry for body-composition assessment of rats exposed to dietary stressors. Nutrition (2001) 1.52
Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. J Infect Dis (1988) 1.52
Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection. J Infect Dis (1987) 1.51
Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun (1981) 1.50
Nosocomial influenza infection as a cause of intercurrent fevers in infants. Pediatrics (1975) 1.46
Respiratory syncytial virus and influenza. Practical community surveillance. Am J Dis Child (1976) 1.36
Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults. J Infect Dis (1998) 1.34
Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin. J Infect Dis (1994) 1.34
Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of U.S. infants. J Clin Microbiol (1993) 1.34
The association of apnea and respiratory syncytial virus infection in infants. J Pediatr (1982) 1.29
Effects of ribavirin on respiratory syncytial virus in vitro. Antimicrob Agents Chemother (1980) 1.28
Quantitative shedding patterns of respiratory syncytial virus in infants. J Infect Dis (1975) 1.28
Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody. J Gen Virol (1990) 1.28